ATE408626T1 - Peptide und ihre verwendung in der diagnostik von kardiovaskulären erkrankungen - Google Patents

Peptide und ihre verwendung in der diagnostik von kardiovaskulären erkrankungen

Info

Publication number
ATE408626T1
ATE408626T1 AT01949734T AT01949734T ATE408626T1 AT E408626 T1 ATE408626 T1 AT E408626T1 AT 01949734 T AT01949734 T AT 01949734T AT 01949734 T AT01949734 T AT 01949734T AT E408626 T1 ATE408626 T1 AT E408626T1
Authority
AT
Austria
Prior art keywords
diagnostics
peptides
cardiovascular diseases
cyclised
affinity
Prior art date
Application number
AT01949734T
Other languages
English (en)
Inventor
Outi Narvanen
Seppo Yla-Herttuala
Original Assignee
Ark Therapeutics Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ark Therapeutics Oy filed Critical Ark Therapeutics Oy
Application granted granted Critical
Publication of ATE408626T1 publication Critical patent/ATE408626T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT01949734T 2000-07-18 2001-07-18 Peptide und ihre verwendung in der diagnostik von kardiovaskulären erkrankungen ATE408626T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0017641.2A GB0017641D0 (en) 2000-07-18 2000-07-18 Peptides and their use

Publications (1)

Publication Number Publication Date
ATE408626T1 true ATE408626T1 (de) 2008-10-15

Family

ID=9895897

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01949734T ATE408626T1 (de) 2000-07-18 2001-07-18 Peptide und ihre verwendung in der diagnostik von kardiovaskulären erkrankungen

Country Status (12)

Country Link
US (2) US20040091934A1 (de)
EP (1) EP1301537B1 (de)
JP (1) JP2004504327A (de)
AT (1) ATE408626T1 (de)
AU (1) AU2001270851A1 (de)
CA (1) CA2417789A1 (de)
DE (1) DE60135846D1 (de)
DK (1) DK1301537T3 (de)
ES (1) ES2312455T3 (de)
GB (1) GB0017641D0 (de)
PT (1) PT1301537E (de)
WO (1) WO2002006314A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030105003A1 (en) 2001-04-05 2003-06-05 Jan Nilsson Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
SE0103754L (sv) * 2001-04-05 2002-10-06 Forskarpatent I Syd Ab Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid
CN1283313C (zh) 2001-09-28 2006-11-08 埃斯佩里安医疗公司 α螺旋状载脂蛋白或HDL关联蛋白在制备局部给药预防和治疗再狭窄的药物中的用途
EP1732383A4 (de) 2004-04-06 2007-05-02 Cedars Sinai Medical Center Vorbeugung und behandlung von gefässerkrankungen mit rekombinanten adeno assoziierten virusvektoren, die für apolipoprotein a-i und apolipoprotein a-i milano kodieren
US7776605B2 (en) * 2006-10-26 2010-08-17 Abbott Laboratories Assay for cardiac troponin autoantibodies
US20080305512A1 (en) * 2006-10-26 2008-12-11 Mattingly Phillip G Assay for cardiac troponin autoantibodies
JP5057402B2 (ja) * 2006-10-26 2012-10-24 アボット・ラボラトリーズ 内在性の抗分析物抗体を含有する試料中の分析物の免疫アッセイ
MX2009006744A (es) * 2006-12-22 2009-06-30 Abbott Lab Panel de padecimiento cardiovascular autoinmune y metodos de utilizacion del mismo.
EP2637689A2 (de) 2010-11-12 2013-09-18 Cedars-Sinai Medical Center Immunmodulatorische verfahren und systeme zur behandlung und/oder prävention von bluthochdruck
US9205139B2 (en) 2010-11-12 2015-12-08 Cardiovax, Llc Immunomodulatory methods and systems for treatment and/or prevention of aneurysms
JP5857312B2 (ja) * 2011-08-11 2016-02-10 積水メディカル株式会社 心疾患診断マーカー
CN107085025B (zh) * 2016-02-15 2019-09-17 太原师范学院 一种自组装三层膜电极及其制备方法和用途
US10858422B2 (en) 2016-05-31 2020-12-08 Abcentra, Llc Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody
US10434141B2 (en) 2016-05-31 2019-10-08 Abcentra, Llc Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody
CN111855986A (zh) * 2019-04-25 2020-10-30 常州博闻迪医药股份有限公司 联合定量检测五项心脏标志物试剂盒及制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5408038A (en) * 1991-10-09 1995-04-18 The Scripps Research Institute Nonnatural apolipoprotein B-100 peptides and apolipoprotein B-100-apolipoprotein A-I fusion peptides
GB9609702D0 (en) * 1996-05-09 1996-07-10 Royal Free Hosp School Med Anticoagulant peptides
GB9705831D0 (en) * 1997-03-20 1997-05-07 Univ Leicester Oxidised ldl
US6635623B1 (en) * 1997-06-13 2003-10-21 Baylor College Of Medicine Lipoproteins as nucleic acid vectors
CA2294355C (en) * 1997-06-20 2006-11-28 Leuven Research & Development Vzw Assays, antibodies, and standards for detection of oxidized and mda-modified low density lipoproteins

Also Published As

Publication number Publication date
DK1301537T3 (da) 2008-12-08
WO2002006314A3 (en) 2002-04-18
WO2002006314A2 (en) 2002-01-24
ES2312455T3 (es) 2009-03-01
US20040091934A1 (en) 2004-05-13
PT1301537E (pt) 2008-12-04
GB0017641D0 (en) 2000-09-06
EP1301537A2 (de) 2003-04-16
CA2417789A1 (en) 2002-01-24
US20080261234A1 (en) 2008-10-23
EP1301537B1 (de) 2008-09-17
JP2004504327A (ja) 2004-02-12
AU2001270851A1 (en) 2002-01-30
DE60135846D1 (de) 2008-10-30

Similar Documents

Publication Publication Date Title
ATE408626T1 (de) Peptide und ihre verwendung in der diagnostik von kardiovaskulären erkrankungen
DK1044374T3 (da) Glucosebiosensor
DE60323231D1 (de) Verkürzte tau proteine
DE60144145D1 (de) Subtilisin-variante
ATE526399T1 (de) Neue biologische einheiten und deren verwendung
DE60322339D1 (de) Bindungsproteine als biosensoren
DK2230299T3 (da) Hidtil ukendt cytokin ZCYTOR17-ligand
NO20052992D0 (no) Markorproteiner for diagnostisering av leversykdom og fremgangsmate for diagnostisering av leversykdom.
DE60330376D1 (de) Defructosylierungsverfahren
DE60313659D1 (de) Borrelidin-derivate und ihre medizinische anwendung
DE60109839D1 (de) Ausgleich der Abnutzung von Spitzen und Fersen
DE60332711D1 (de) Neue insektizide proteine von bazillus thuringiensis
ATE335763T1 (de) Sandwich-immunoassay zur bestimmung von proanp- teilpeptiden
WO2002030959A3 (en) Peptides derived from smac (diablo) and methods of use therefor
SE8801701D0 (sv) Production technology based on enzymic method
DE69737651D1 (de) Cortistatin: neuropeptide, zusammensetzungen und methoden
DK1257829T3 (da) Komplementationsassay der vurderer proteinoplöselighed og -foldning
ATE369442T1 (de) In vitro evolution von nukleinsäuren und kodierten polypeptiden
ATE333513T1 (de) Verfahren und zusammensetzungen zur überwachung der modifikation von natürlichen bindungspartners
WO2002102847A1 (fr) Nouveau ligand et son adn
ATE389029T1 (de) Protease assay zur kontrolle medikamentöser therapie
ATE458810T1 (de) Aggrecanase-1- und -2-peptidsubstrate und verfahren
ATE309193T1 (de) Mischungen von halbestern mehrbasiger organischer säuren und langkettiger alkanole,ihre herstellung und verwendung
ATE403863T1 (de) Verfahren zum nachweis von intrazellulären atp und/oder genexpression
WO2002046769A3 (en) A monoclonal antibody-based diagnostic assay for gamma fibrinogen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1301537

Country of ref document: EP

REN Ceased due to non-payment of the annual fee